Literature DB >> 25672885

Macaque species susceptibility to simian immunodeficiency virus: increased incidence of SIV central nervous system disease in pigtailed macaques versus rhesus macaques.

Sarah E Beck1, Kathleen M Kelly, Suzanne E Queen, Robert J Adams, M Christine Zink, Patrick M Tarwater, Joseph L Mankowski.   

Abstract

Immune pressure exerted by MHC class I-restricted cytotoxic T cells drives the development of viral escape mutations, thereby regulating HIV disease progression. Nonetheless, the relationship between host immunity and HIV central nervous system (CNS) disease remains poorly understood. The simian immunodeficiency virus (SIV) macaque model recapitulates key features of HIV infection including development of AIDS and CNS disease. To investigate cell-mediated immunity regulating SIV CNS disease progression, we compared the incidence of SIV encephalitis and the influence of MHC class I allele expression on the development of CNS disease in rhesus macaques (Macaca mulatta) versus pigtailed macaques (Macaca nemestrina). After inoculation with the immunosuppressive swarm SIV/DeltaB670 and the neurovirulent molecular clone SIV/17E-Fr, pigtailed macaques progressed more rapidly to AIDS, had higher plasma and cerebrospinal fluid (CSF) viral loads, and were more likely to progress to SIV-associated encephalitis (SIVE) compared to rhesus macaques. In addition, MHC class I alleles were neuroprotective in both species (Mamu-A*001 in rhesus macaques and Mane-A1*084:01:01 in pigtailed macaques); animals expressing these alleles were less likely to develop SIV encephalitis and correspondingly had lower viral replication in the brain. Species-specific differences in susceptibility to SIV disease demonstrated that cell mediated immune responses are critical to SIV CNS disease progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25672885     DOI: 10.1007/s13365-015-0313-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  46 in total

Review 1.  Control of HIV-1 replication in elite suppressors.

Authors:  Joel N Blankson
Journal:  Discov Med       Date:  2010-03       Impact factor: 2.970

2.  Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model.

Authors:  C Jane Batten; Robert De Rose; Kim M Wilson; Michael B Agy; Socheata Chea; Ivan Stratov; David C Montefiori; Stephen J Kent
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

3.  Spectrum of disease in macaque monkeys chronically infected with SIV/SMM.

Authors:  H M McClure; D C Anderson; P N Fultz; A A Ansari; E Lockwood; A Brodie
Journal:  Vet Immunol Immunopathol       Date:  1989-05       Impact factor: 2.046

4.  Impact of various simian immunodeficiency virus variants on induction and nature of neuropathology in macaques.

Authors:  S Czub; J G Müller; M Czub; H K Müller-Hermelink
Journal:  Res Virol       Date:  1996 Mar-Jun

5.  Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques.

Authors:  Victoria A Laast; Beom Shim; Lisa M Johanek; Jamie L Dorsey; Peter E Hauer; Patrick M Tarwater; Robert J Adams; Carlos A Pardo; Justin C McArthur; Matthias Ringkamp; Joseph L Mankowski
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

6.  ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.

Authors:  R Pal; D Venzon; N L Letvin; S Santra; D C Montefiori; N R Miller; E Tryniszewska; M G Lewis; T C VanCott; V Hirsch; R Woodward; A Gibson; M Grace; E Dobratz; P D Markham; Z Hel; J Nacsa; M Klein; J Tartaglia; G Franchini
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 7.  Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  N L Letvin; N W King
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

8.  Genetic characterization of specific pathogen-free rhesus macaque (Macaca mulatta) populations at the California National Primate Research Center (CNPRC).

Authors:  Sree Kanthaswamy; Alex Kou; Jessica Satkoski; Maria Cecilia T Penedo; Thea Ward; Jillian Ng; Leanne Gill; Nicholas W Lerche; Bethany J-A Erickson; David Glenn Smith
Journal:  Am J Primatol       Date:  2010-06       Impact factor: 2.371

9.  MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Thorsten Mühl; Michael Krawczak; Peter Ten Haaft; Gerhard Hunsmann; Ulrike Sauermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  HIV-1-induced AIDS in monkeys.

Authors:  Theodora Hatziioannou; Gregory Q Del Prete; Brandon F Keele; Jacob D Estes; Matthew W McNatt; Julia Bitzegeio; Alice Raymond; Anthony Rodriguez; Fabian Schmidt; C Mac Trubey; Jeremy Smedley; Michael Piatak; Vineet N KewalRamani; Jeffrey D Lifson; Paul D Bieniasz
Journal:  Science       Date:  2014-06-20       Impact factor: 47.728

View more
  19 in total

1.  Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.

Authors:  Joann L Yee; Michael B McChesney; Kari L Christe
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

Review 2.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

Review 3.  Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

Authors:  Sarah E Beck; Suzanne E Queen; Kenneth W Witwer; Kelly A Metcalf Pate; Lisa M Mangus; Lucio Gama; Robert J Adams; Janice E Clements; M Christine Zink; Joseph L Mankowski
Journal:  Eur J Pharmacol       Date:  2015-03-24       Impact factor: 4.432

4.  Tracking Epidermal Nerve Fiber Changes in Asian Macaques: Tools and Techniques for Quantitative Assessment.

Authors:  Lisa M Mangus; Jamie L Dorsey; Rachel L Weinberg; Gigi J Ebenezer; Peter Hauer; Victoria A Laast; Joseph L Mankowski
Journal:  Toxicol Pathol       Date:  2016-05-27       Impact factor: 1.902

5.  Genetic Characterization of a Captive Colony of Pigtailed Macaques (Macaca nemestrina).

Authors:  Xinjun Zhang; Sree Kanthaswamy; Jessica S Trask; Jillian Ng; Robert F Oldt; Joseph L Mankowski; Robert J Adams; David G Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-07-01       Impact factor: 1.232

Review 6.  An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV that target activated monocytes and macrophages.

Authors:  Jaclyn Mallard; Kenneth Williams
Journal:  J Neurovirol       Date:  2018-02-12       Impact factor: 2.643

7.  Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control.

Authors:  Sarah E Beck; Suzanne E Queen; Raphael Viscidi; Darius Johnson; Stephen J Kent; Robert J Adams; Patrick M Tarwater; Joseph L Mankowski
Journal:  J Neurovirol       Date:  2016-01-04       Impact factor: 2.643

Review 8.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

Review 9.  Non-human primate models of SIV infection and CNS neuropathology.

Authors:  Kenneth Williams; Andrew Lackner; Jaclyn Mallard
Journal:  Curr Opin Virol       Date:  2016-08-18       Impact factor: 7.090

Review 10.  An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.

Authors:  Sarah E Beck; Suzanne E Queen; Kelly A Metcalf Pate; Lisa M Mangus; Celina M Abreu; Lucio Gama; Kenneth W Witwer; Robert J Adams; M Christine Zink; Janice E Clements; Joseph L Mankowski
Journal:  J Neurovirol       Date:  2017-10-03       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.